Fogorvosi szemle, 2013 (106. évfolyam, 1-4. szám)
2013-06-01 / 2. szám
FOGORVOSI SZEMLE 106. évf. 2. sz. 2013. 69 8. Cebeci I, Kantarci A, Firatli E, Carin M, Tencer Ö.: The effect of verapamil on the prevalence and severity of cyclosporine-induced qinqival overqrowth in renal aloqraft recipients. J Clin Periodontol 1996; 67: 1201-1205. 9. Cobb CM.: Non-surgical pocket therapy: mechanical. Ann Periodontol 1996; 1:443-490. 10. Cota L. O. M., Aquino D. R, Franco GCN, Cortelli JR, Cortelli SC And Costa FO.: Gingival overgrowth in subjects under immunosuppressive regimens based on cyclosporine, tacrolimus, or sirolimus. Journal of Clinical Peridontology 2010; 37: 894-902. 11. Dorfman HS, Kennedy JE, Bird WC.: Longitudinal evaluation of free autogoneous gingival grafts. J Clin Periodontol 1980:7:316-324. 12. Ellegaard B, Bergmann OJ, Ellegard J.: Effect of plaque removal on patients with leukemia. J Oral Pathol Med 1989; 18: 54-58. 13. Evans, DB, Henderson R, Hamilton DC, Boone N, és mtsai: Cyclosporin-A in clinical organ grafting. Transplant Proc 1981 ; 13: 349-358. 14. Fleckenstein A.: History of Calcium Antagonist Circ. Res 52. /suppi I. /3-16, 1983. 15. Gera I és mtsai: Parodontólogia tankönyv. Semmelweis Kiadó, 2009. 7. fejezet: 158-161. 16. Gera I és mtsai: Parodontólogia tankönyv. Semmelweis Kiadó, 2009; 12. fejezet: 335-336. 17. Hassel TM.: Evidence for production of an inactive collage-nase by fibroblasts from phenitoin-enlarged human gingivae. J Oral Pathol II, 310, 1982. 18. Hermann P, Gera I, Borbély J, Fejérdy P, Madléna M.: Periodontal health of an adult population in Hungary: findings of a national survey. J Clin Periodontol 2009; 36: 449-457. 19. Horning GM, Fischer JG, Barker F, Killoy WJ & Lowe JW.: Ginqival fibromatosis with hypertrichosis. J Periodontol 1985; 56: 344-347. 20. Keglevich T, Benedek E, Gera I.: A kálciumcsatorna-blokkoló szerek okozta ínyhyperplasia kezelésének klinikai tapasztalatai. Fogorv Szle 1999; 92: 363-372. 21. Keglevich T, Benedek E, Gera I.: A kálciumcsatorna-blokkolók okozta ínyhyperplasia. Lege Artis Med 1999; 9: 164-168. 22. Khocht, A, Schneider, LC.: Periodontal management of gingival overgrowth in the heart transplant patient: A case report. J Clin Periodontol 1997; 68: 1140-1146. 23. Lederman D, Lumerman H, Reuben S, Freadman PD.: Gingival hyperplasia associated with nifedipin therapy. Oral Surg 1984; 54: 620-622. 24. Lisa JA. Heitz-Mayfield.: How effective is surgical therapy compared with nonsurgical debridement? Periodontology 2000, 2005; 37: 72-87. 25. Miller CS, Damm DD.: Verapamil induced gingival hyperplasia in a dental population . J. Periodontol 1992; 63: 435—456. 26. Miller, PJ.: A classification of marginal tissue recession. International Journal of Periodontics and Restorative Dentistry 1983; 5: 8-13. 27. Nery EB, Edson RG, Lee KK, Pruthi VK, Watson J.: Prevalence of nifedipine-induced gingival hyperplasia. J. Periodontol 1995; 66: 572-578. 28. Nakamura S, Hiroki A, Shinohara M, et al.: Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 556-63. 29. Nishikawa S, Toda H, Hamasaki A, Kasahora S, és mtsai: Nifedipine-induced gingival hyperplasia: a clinical and in vitro study. J. Periodontol 1991; 62: 30. 30. Nisikawa S, Nagata T, Morisaki I, Oka T, Ishida H.: Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. J. Periodontol 1996; 67: 463-471. 31. Noce Cw, Gomes A, Copello A, Barbosa RD és mtsai: Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients. Gen Dent. 2011; 59: 458-62; quiz 463-4. 32. Pilloni A, Camargo PM, Carera M, Carranza FA.: Surgical treatment of cyclosporine A and Nifedipne-induced gingival enlargement: Gingivectomy versus periodontal flap. J Periodontol 1998; 69: 791-797. 44. 33. Rostock MH, Fry HR, Turner JE.: Severe gingival overgrowth associated with cyclosporin therapy. J Periodontol 1986; 57: 294- 299. 34. Salo J, Oilarinez KS, Oilarinez A.: Effect of phenitoin and nifedipine on collagen gene expression in normal human fibroblast. J Oral Pathol Med. 1990; 19: 404. 35. Seymour RA.: Calcium channel blocker and gingival overgrowth. Br Dent J1991 ; 170: 376-379. 36. Seymour RA, Ellis JS, Thomson JM, Monkman S, Idle IB.: Amilodipine-induced gingival overgrowth. J Clin Periodontol 1994; 21: 281-283. 37. Sibaud V, Marit G, Deminiere C, Campana F, Taieb A, Fricain JC.: Multiple verruciform xanthomas of the oral mucosa associated with graft versus host disease. Ann Dermatol Venereol. 2006; 133: 995-999. 38. Stewart C, Cohen D, Bhattacharyya I, Scheitler L, és mtsai.: Oral manifestations of Wegener’s granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 2007; 138: 338-48. 39. Suvan JE: Effectiveness of mechanical nonsurgical pocket therapy. Periodontology 2000, 2005; 37: 48-71. 40. Treister NS, Cook EF JR, Antin J, Lee ST, Soiffer R, Woo SB.: Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 2008; 14:110-115. 41. Wennström J, Lindhe J, Nyman S.: Role of keratinized gingiva for gingival health. Clinical and histologic study of normal and regenerated gingival tissues in dogs. J Clin Periodontol 1981: 8: 311-328. 42. Wennström J, Lindhe J.: Role of attached gingiva for maintenance of periodontal health. Healing following excisional and grafting procedures in dogs. J Clin Periodontol 1983: 10: 206-211.